Wall Street Experts
ver. ZuMIgo(08/25)
Inter Pharma Public Company Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 1 790
EBIT TTM (mln): 34
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
247 |
314 |
371 |
442 |
909 |
1,523 |
1,781 |
1,897 |
Przychód Δ r/r |
0.0% |
26.8% |
18.4% |
19.1% |
105.5% |
67.7% |
16.9% |
6.5% |
Marża brutto |
59.9% |
60.1% |
57.6% |
59.0% |
44.1% |
40.6% |
36.6% |
37.4% |
EBIT (mln) |
29 |
41 |
62 |
78 |
146 |
172 |
92 |
76 |
EBIT Δ r/r |
0.0% |
43.0% |
50.2% |
27.3% |
86.1% |
17.8% |
-46.5% |
-17.8% |
EBIT (%) |
11.6% |
13.1% |
16.6% |
17.7% |
16.0% |
11.3% |
5.2% |
4.0% |
Koszty finansowe (mln) |
0 |
0 |
1 |
1 |
8 |
23 |
26 |
20 |
EBITDA (mln) |
29 |
42 |
64 |
83 |
172 |
236 |
190 |
185 |
EBITDA(%) |
11.9% |
13.4% |
17.1% |
18.9% |
19.0% |
15.5% |
10.7% |
9.8% |
Podatek (mln) |
9 |
11 |
14 |
17 |
27 |
20 |
22 |
16 |
Zysk Netto (mln) |
16 |
30 |
43 |
53 |
105 |
119 |
51 |
37 |
Zysk netto Δ r/r |
0.0% |
88.8% |
46.5% |
20.9% |
100.3% |
13.0% |
-57.3% |
-26.6% |
Zysk netto (%) |
6.4% |
9.5% |
11.7% |
11.9% |
11.6% |
7.8% |
2.9% |
2.0% |
EPS |
0.0766 |
0.13 |
0.15 |
0.13 |
0.36 |
0.36 |
0.14 |
0.0616 |
EPS (rozwodnione) |
0.0542 |
0.13 |
0.15 |
0.13 |
0.36 |
0.36 |
0.14 |
0.0616 |
Ilośc akcji (mln) |
205 |
237 |
290 |
407 |
292 |
327 |
373 |
605 |
Ważona ilośc akcji (mln) |
290 |
237 |
290 |
407 |
292 |
327 |
373 |
605 |
Waluta |
THB |
THB |
THB |
THB |
THB |
THB |
THB |
THB |